-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 4, the Guangdong Pharmaceutical Trade Center issued the official version of the "Guangdong Union Amoxicillin and Other 45 Pharmaceutical Groups Procurement Documents", announcing the official start of this large-scale inter-provincial alliance mass procurement!
The initial reporting documents of the Pharmaceutical Purchasing Alliance led by Guangdong Province show that Shanxi, Fujian, Jiangxi, Henan, Hubei, Hunan, Guangxi, Hainan, Guizhou, Yunnan, Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang and other provinces (autonomous regions) have medical insurance The Bureau and the Medical Security Bureau of the Xinjiang Production and Construction Corps issued an invitation, covering a total of 16 provinces and regions, covering half of China
On July 17 this year, the Guangdong Drug Trade Center issued the "Draft for Solicitation of Comments".
According to the "Procurement Documents", the scope of the drug group's bulk purchases is the first and third batches of the country's first and third batches of all the dosage forms and specifications of 45 drugs of the same variety, including amoxicillin, which expires at the end of 2021.
As of the date of the issuance of this procurement document, the number of generic drugs that have passed (including deemed approval, the same below) consistency evaluation exceeds one (including this number) and the dosage form of the national medical insurance drug catalog is not included in this collection.
Flurbiprofen sustained-release and controlled-release dosage form is an exclusive variety and has been discontinued.
In principle, the volume procurement cycle for the drug alliance area of this product range does not exceed two years, and it will be calculated from the actual implementation date of the selected results
In addition, it should be noted that when the purchase period of the first year ends and the purchase agreement is renewed in the second year, if the actual purchase volume of the selected company exceeds the total amount of pre-purchasing in the first year of the purchase period and the second-tier quotation is not executed, the renewal price will be taken The company's second-tier quotation
The following is a brief catalog:
